Individuals Coming Off Anti-Obesity Jabs Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets
Fresh analysis indicates that individuals who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who halt conventional lifestyle plans.
Research printed in a prominent health publication shows that while obese people can lose about a fifth of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users using such medications need to be cognizant of the risk of rapid rebound weight gain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to original mass in about one and a half years.
Weighing Therapies
The research, which reviewed dozens of studies involving over 9,000 of participants, compared the results of GLP-1 agonists with other pills.
Scientists point out that individuals who lose weight through lifestyle changes alone usually have a less rapid creep back—around 0.1 kg a month—post-intervention.
Explaining the Rapid Regain
Doctors suggest the mechanism of the jabs explains the accelerated regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making overeating far more likely."
An Ongoing Disease?
Medical guidelines recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, given the likelihood of relapse, the treatment should be considered life-long.
This view is echoed by drug manufacturers, who state that the results "highlight the persistent character of excess weight," comparing it to managing diseases like hypertension.
User Experiences
Individuals who have stopped the medication describe a powerful resurgence of cravings.
"It was like a switch that goes on and you're instantly starving," said one woman.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Use
Survey data show that millions of people in the UK have tried these injections in the past year, with desire remaining high.
- Use is greater among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while the jabs are powerful tools for weight loss, they are not a standalone fix and lasting health benefits relies on ongoing lifestyle support.
